دورية أكاديمية
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]
| العنوان: | [Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.] |
|---|---|
| عنوان ترانسليتريتد: | Gestione del paziente con microcitoma a stadio esteso. L’importanza della collaborazione tra oncologia e radioterapia. |
| المؤلفون: | Minuti G; Ifo - Oncologia medica 2, Irccs Istituto nazionale tumori Regina Elena, Roma., Stefani A; Uoc Oncologia medica, Policlinico universitario Agostino Gemelli, Roma., Trodella L; Uoc Radioterapia oncologica, Campus Biomedico, Roma., Antonini Cappellini G; Uoc Oncologia, Ospedale Sandro Pertini, Roma., Cecere F; Ifo - Oncologia medica 2, Irccs Istituto nazionale tumori Regina Elena, Roma., Dionisi F; Uoc Radioterapia, Irccs Istituto nazionale tumori Regina Elena, Roma., Di Salvatore M; Uoc Oncologia medica, Policlinico universitario Agostino Gemelli, Roma., Mariotti S; Uosd Oncologia medica, Policlinico Tor Vergata, Università di Roma Tor Vergata., Mazzarella C; Uoc Radioterapia, Policlinico universitario Agostino Gemelli, Roma., Nelli F; Uoc Oncologia, AO Belcolle, Viterbo., Pisegna S; Uoc Oncologia medica, Policlinico Umberto I, Sapienza Università di Roma., Ricciardi S; Uoc Pneumologia oncologica, AO San Camillo-Forlanini, Roma., Russano M, Ramella S; Uoc Radioterapia oncologica, Campus Biomedico, Roma., Bria E; Uoc Oncologia medica, Policlinico universitario Agostino Gemelli, Roma - Comprehensive Cancer Center, Fondazione Policlinico universitario Agostino Gemelli, Irccs Roma., Cappuzzo F; Ifo - Oncologia medica 2, Irccs Istituto nazionale tumori Regina Elena, Roma. |
| المصدر: | Recenti progressi in medicina [Recenti Prog Med] 2023 Jul-Aug; Vol. 114 (7), pp. 414-425. |
| نوع المنشور: | English Abstract; Journal Article |
| اللغة: | Italian |
| بيانات الدورية: | Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 0401271 Publication Model: Print Cited Medium: Internet ISSN: 2038-1840 (Electronic) Linking ISSN: 00341193 NLM ISO Abbreviation: Recenti Prog Med Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Roma : Il Pensiero Scientifico Editore |
| مواضيع طبية MeSH: | Medical Oncology* , Physicians*, Humans ; Patients ; Immunotherapy |
| مستخلص: | Small cell lung cancer (SCLC) represents one of the most complex challenges in the oncological field, with a very slow advancement in research, contrary to the rapid evolutionary of the disease. For nearly two years, the mainstay of treatment for extensive-stage disease (ES-SCLC) has been the combination of platinum-based chemotherapy and immunotherapy, following the approval of atezolizumab and subsequently durvalumab, based on a modest, but significant improvement in overall survival compared to chemotherapy alone. The poor prognosis after the failure of first-line treatment explains the need to maximize the duration and efficacy of up-front systemic therapies, in particular, the emerging role of radiotherapy, also in ES-SCLC. On 10 November 2022, a meeting concerning the integrated treatment of patients with ES-SCLC was held in Rome and was attended by 12 specialists in oncology and radiotherapy from various centers in Lazio, under the direction of Federico Cappuzzo, Emilio Bria and Sara Ramella. The aim of the meeting was to share their clinical experience and to provide a series of practical indications in order to support physicians in the correct integration between first-line chemo-immunotherapy and radiotherapy treatments in ES-SCLC. |
| تواريخ الأحداث: | Date Created: 20230701 Date Completed: 20230703 Latest Revision: 20231120 |
| رمز التحديث: | 20231120 |
| DOI: | 10.1701/4062.40460 |
| PMID: | 37392104 |
| قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!